Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do researchers quickly update shots to keep up with mutations?

Scandal: Undeclared Toxic Elements Discovered in COVID Vaccines** New revelations concerning the COVID-19 vaccines have sparked serious health concerns as Argentine scientists r ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

Respiratory virus season is here and health officials emphasize that October is the optimal time for vaccinations to prevent severe illness. Vaccines for COVID-19, influenza and RSV are currently ...

As of 2024, there are three COVID-19 vaccines approved for use by the U.S. Food and Drug Administration (FDA): Pfizer-BioNTech (marketed under the brand name Comirnaty), an mRNA vaccine Moderna ...

Al­ny­lam Phar­ma­ceu­ti­cals has agreed to drop its 2023 patent law­suit against Mod­er­na in a Delaware court fol­low­ing a judge’s rul­ing in Sep­tem­ber.

Last month, Health Canada approved Pfizer and Moderna’s latest COVID-19 vaccines targeting the most recent variants of the virus. Both shots are approved for everyone aged six months and older.

Other companies, including Pfizer and Moderna, are continuing efforts to develop an mRNA bird flu vaccine, which is the same technology used in the companies' respective COVID-19 vaccines.

Concession is based on Sept. 10 claim-construction order Moderna’s win comes in broader vaccine delivery-tech fight Alnylam Pharmaceuticals Inc. dropped a lawsuit against Moderna Inc. over delivery ...